Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Mallmann RT, Klugbauer N. Genetic Inactivation of Two-Pore Channel 1 Impairs Spatial Learning and Memory. Behav Genet 2020;50:401-410. [PMID: 32889694 PMCID: PMC7581579 DOI: 10.1007/s10519-020-10011-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Accepted: 07/28/2020] [Indexed: 12/16/2022]

For:	Mallmann RT, Klugbauer N. Genetic Inactivation of Two-Pore Channel 1 Impairs Spatial Learning and Memory. Behav Genet 2020;50:401-410. [PMID: 32889694 PMCID: PMC7581579 DOI: 10.1007/s10519-020-10011-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Accepted: 07/28/2020] [Indexed: 12/16/2022]

Number

Cited by Other Article(s)

Chadwick SR, Barreda D, Wu JZ, Ye G, Yusuf B, Ren D, Freeman SA. Two-pore channels regulate endomembrane tension to enable remodeling and resolution of phagolysosomes. Proc Natl Acad Sci U S A 2024;121:e2309465121. [PMID: 38354262 PMCID: PMC10895354 DOI: 10.1073/pnas.2309465121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Accepted: 12/21/2023] [Indexed: 02/16/2024] Open

Vuic B, Milos T, Tudor L, Nikolac Perkovic M, Konjevod M, Nedic Erjavec G, Farkas V, Uzun S, Mimica N, Svob Strac D. Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. Genes (Basel) 2023;14:2048. [PMID: 38002991 PMCID: PMC10671071 DOI: 10.3390/genes14112048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 10/30/2023] [Accepted: 11/02/2023] [Indexed: 11/26/2023] Open

Affiliation(s)

Barbara Vuic Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Tina Milos Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Lucija Tudor Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Matea Nikolac Perkovic Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Marcela Konjevod Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Gordana Nedic Erjavec Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Vladimir Farkas Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)
Suzana Uzun Department for Biological Psychiatry and Psychogeriatry, University Hospital Vrapce, 10000 Zagreb, Croatia; (S.U.); (N.M.) School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Ninoslav Mimica Department for Biological Psychiatry and Psychogeriatry, University Hospital Vrapce, 10000 Zagreb, Croatia; (S.U.); (N.M.) School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
Dubravka Svob Strac Laboratory for Molecular Neuropsychiatry, Division of Molecular Medicine, Rudjer Boskovic Institute, 10000 Zagreb, Croatia; (B.V.); (T.M.); (L.T.); (M.N.P.); (M.K.); (G.N.E.); (V.F.)

Collapse

Kaivola K, Chia R, Ding J, Rasheed M, Fujita M, Menon V, Walton RL, Collins RL, Billingsley K, Brand H, Talkowski M, Zhao X, Dewan R, Stark A, Ray A, Solaiman S, Alvarez Jerez P, Malik L, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Masellis M, Keith J, Black SE, Ferrucci L, Resnick SM, Tanaka T, Topol E, Torkamani A, Tienari P, Foroud TM, Ghetti B, Landers JE, Ryten M, Morris HR, Hardy JA, Mazzini L, D'Alfonso S, Moglia C, Calvo A, Serrano GE, Beach TG, Ferman T, Graff-Radford NR, Boeve BF, Wszolek ZK, Dickson DW, Chiò A, Bennett DA, De Jager PL, Ross OA, Dalgard CL, Gibbs JR, Traynor BJ, Scholz SW. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias. CELL GENOMICS 2023;3:100316. [PMID: 37388914 PMCID: PMC10300553 DOI: 10.1016/j.xgen.2023.100316] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Revised: 03/21/2023] [Accepted: 04/06/2023] [Indexed: 07/01/2023]

Affiliation(s)

Karri Kaivola Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
Ruth Chia Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
Jinhui Ding Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
Memoona Rasheed Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
Masashi Fujita Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, NY, USA
Vilas Menon Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, NY, USA
Ronald L. Walton Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA
Ryan L. Collins Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology (M.I.T.), Cambridge, MA, USA Division of Medical Sciences and Department of Medicine, Harvard Medical School, Boston, MA, USA
Kimberley Billingsley Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA Centre for Alzheimer’s and Related Dementias, National Institute on Aging, Bethesda, MD, USA
Harrison Brand Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology (M.I.T.), Cambridge, MA, USA Division of Medical Sciences and Department of Medicine, Harvard Medical School, Boston, MA, USA
Michael Talkowski Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology (M.I.T.), Cambridge, MA, USA Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Xuefang Zhao Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology (M.I.T.), Cambridge, MA, USA
Ramita Dewan Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
Ali Stark Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
Anindita Ray Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
Sultana Solaiman Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
Pilar Alvarez Jerez Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA Centre for Alzheimer’s and Related Dementias, National Institute on Aging, Bethesda, MD, USA
Laksh Malik Centre for Alzheimer’s and Related Dementias, National Institute on Aging, Bethesda, MD, USA
Ted M. Dawson Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA Neuroregeneration and Stem Cell Programs, Institute of Cell Engineering, Johns Hopkins University Medical Center, Baltimore, MD, USA Department of Pharmacology and Molecular Science, Johns Hopkins University Medical Center, Baltimore, MD, USA Solomon H. Snyder Department of Neuroscience, Johns Hopkins University Medical Center, Baltimore, MD, USA
Liana S. Rosenthal Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA
Marilyn S. Albert Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA
Olga Pletnikova Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA Department of Pathology (Neuropathology), Johns Hopkins University Medical Center, Baltimore, MD, USA
Juan C. Troncoso Department of Pathology (Neuropathology), Johns Hopkins University Medical Center, Baltimore, MD, USA
Mario Masellis Cognitive & Movement Disorders Clinic, Sunnybrook Health Sciences Centre, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada
Julia Keith Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada
Sandra E. Black Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada Institute of Medical Science, Faculty of Medicine, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada
Luigi Ferrucci Longitudinal Studies Section, National Institute on Aging, Baltimore, MD, USA
Susan M. Resnick Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA
Toshiko Tanaka Longitudinal Studies Section, National Institute on Aging, Baltimore, MD, USA
PROSPECT Consortium Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, NY, USA Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology (M.I.T.), Cambridge, MA, USA Division of Medical Sciences and Department of Medicine, Harvard Medical School, Boston, MA, USA Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA Centre for Alzheimer’s and Related Dementias, National Institute on Aging, Bethesda, MD, USA Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA Neuroregeneration and Stem Cell Programs, Institute of Cell Engineering, Johns Hopkins University Medical Center, Baltimore, MD, USA Department of Pharmacology and Molecular Science, Johns Hopkins University Medical Center, Baltimore, MD, USA Solomon H. Snyder Department of Neuroscience, Johns Hopkins University Medical Center, Baltimore, MD, USA Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA Department of Pathology (Neuropathology), Johns Hopkins University Medical Center, Baltimore, MD, USA Cognitive & Movement Disorders Clinic, Sunnybrook Health Sciences Centre, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, University of Toronto, 2075 Bayview Avenue, Toronto, ON, Canada Department of Anatomical Pathology, Sunnybrook Health Sciences Centre, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada Institute of Medical Science, Faculty of Medicine, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, University of Toronto, 1 King’s College Circle, Room 2374, Toronto, ON, Canada Longitudinal Studies Section, National Institute on Aging, Baltimore, MD, USA Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA Translational Immunology, Research Programs Unit, University of Helsinki, Helsinki, Finland Department of Neurology, Helsinki University Hospital, Helsinki, Finland Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA Department of Genetics and Genomic Medicine Research & Teaching, UCL GOS Institute of Child Health, University College London, London, UK Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK UCL Movement Disorders Centre, University College London, London, UK UK Dementia Research Institute, Department of Neurogenerative Disease and Reta Lila Weston Institute, London, UK Institute of Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China Maggiore della Carita University Hospital, Novara, Italy Department of Health Sciences, University of Eastern Piedmont, Novara, Italy Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy Azienda Ospedaliero Universitaria Città, della Salute e della Scienza, Corso Bramante, 88, Turin, Italy Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, USA Department of Psychiatry and Psychology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA Department of Neurology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA Institute of Cognitive Sciences and Technologies, C.N.R., Via S. Martino della Battaglia, 44, Rome, Italy Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA The American Genome Center, Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA RNA Therapeutics Laboratory, Therapeutics Development Branch, National Center for Advancing Translational Sciences, Rockville, MD, USA
Eric Topol Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA
Ali Torkamani Scripps Research Translational Institute, Scripps Research, La Jolla, CA, USA
Pentti Tienari Translational Immunology, Research Programs Unit, University of Helsinki, Helsinki, Finland Department of Neurology, Helsinki University Hospital, Helsinki, Finland
Tatiana M. Foroud Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
Bernardino Ghetti Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
John E. Landers Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA
Mina Ryten Department of Genetics and Genomic Medicine Research & Teaching, UCL GOS Institute of Child Health, University College London, London, UK Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, UK
Huw R. Morris Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK UCL Movement Disorders Centre, University College London, London, UK
John A. Hardy Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK UCL Movement Disorders Centre, University College London, London, UK UK Dementia Research Institute, Department of Neurogenerative Disease and Reta Lila Weston Institute, London, UK Institute of Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China
Letizia Mazzini Maggiore della Carita University Hospital, Novara, Italy
Sandra D'Alfonso Department of Health Sciences, University of Eastern Piedmont, Novara, Italy
Cristina Moglia Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy Azienda Ospedaliero Universitaria Città, della Salute e della Scienza, Corso Bramante, 88, Turin, Italy
Andrea Calvo Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy Azienda Ospedaliero Universitaria Città, della Salute e della Scienza, Corso Bramante, 88, Turin, Italy
Geidy E. Serrano Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, USA
Thomas G. Beach Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, USA
Tanis Ferman Department of Psychiatry and Psychology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA
Neill R. Graff-Radford Department of Neurology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA
Bradley F. Boeve Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA
Zbigniew K. Wszolek Institute of Cognitive Sciences and Technologies, C.N.R., Via S. Martino della Battaglia, 44, Rome, Italy
Dennis W. Dickson Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA
Adriano Chiò Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy Azienda Ospedaliero Universitaria Città, della Salute e della Scienza, Corso Bramante, 88, Turin, Italy Institute of Cognitive Sciences and Technologies, C.N.R., Via S. Martino della Battaglia, 44, Rome, Italy
David A. Bennett Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
Philip L. De Jager Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, NY, USA
Owen A. Ross Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, USA
Clifton L. Dalgard Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA The American Genome Center, Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
J. Raphael Gibbs Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
Bryan J. Traynor Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA RNA Therapeutics Laboratory, Therapeutics Development Branch, National Center for Advancing Translational Sciences, Rockville, MD, USA
Sonja W. Scholz Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA

Collapse

Just A, Mallmann RT, Grossmann S, Sleman F, Klugbauer N. Two-pore channel protein TPC1 is a determining factor for the adaptation of proximal tubular phosphate handling. Acta Physiol (Oxf) 2023;237:e13914. [PMID: 36599408 DOI: 10.1111/apha.13914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 10/27/2022] [Accepted: 01/02/2023] [Indexed: 01/06/2023]

Galione A, Davis LC, Martucci LL, Morgan AJ. NAADP-Mediated Ca²⁺ Signalling. Handb Exp Pharmacol 2023;278:3-34. [PMID: 35879580 DOI: 10.1007/164_2022_607] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]

Two-pore channels: going with the flows. Biochem Soc Trans 2022;50:1143-1155. [PMID: 35959977 PMCID: PMC9444070 DOI: 10.1042/bst20220229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2022] [Revised: 07/21/2022] [Accepted: 07/25/2022] [Indexed: 11/26/2022]

Martucci LL, Cancela JM. Neurophysiological functions and pharmacological tools of acidic and non-acidic Ca2+ stores. Cell Calcium 2022;104:102582. [DOI: 10.1016/j.ceca.2022.102582] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Revised: 03/07/2022] [Accepted: 03/23/2022] [Indexed: 02/08/2023]

Fu CH, Han XY, Tong L, Nie PY, Hu YD, Ji LL. miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 2021;414:113485. [PMID: 34302879 DOI: 10.1016/j.bbr.2021.113485] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Revised: 05/20/2021] [Accepted: 07/17/2021] [Indexed: 01/20/2023]

Abstract

MicroRNA-142-5p (miR-142-5p) has been found to be dysregulated in several neurodegenerative disorders. However, little is known about the involvement of miR-142-5p in Alzheimer's disease (AD). Brain angiogenesis inhibitor 3 (BAI3), which belongs to the adhesion-G protein-coupled receptor subgroup, contributes to a variety of neuropsychiatric disorders. Despite its very high expression in neurons, the role of BAI3 in AD remains elusive, and its mechanism at the cellular and molecular levels needs to be further elucidated. The current study sought to investigate whether miR-142-5p influenced BAI3 expression and neuronal synaptotoxicity induced by Aβ, both in APP/PS1 transgenic mice and a cellular model of Alzheimer's disease. Altered expression of miR-142-5p was found in the hippocampus of AD mice. Inhibition of miR-142 could upregulate BAI3 expression, enhance neuronal viability and prevent neurons from undergoing apoptosis. In addition, the reduction of phosphorylation of Synapsin I and calcium/calmodulin-dependent protein kinase II (CaMKII), as well as the expression of PSD-95 in the hippocampus of APP/PS1 transgenic mice, were significantly restored by inhibiting miR-142. Meanwhile, the levels of Aβ_1-42, β-APP, BACE-1 and PS-1 in cultured neurons were detected, and the effects of inhibiting miR-142 on spatial learning and memory were also observed. Interestingly, we found that BAI3, an important regulator of excitatory synapses, was a potential target gene of miR-142-5p. Collectively, our findings suggest that miR-142 inhibition can alleviate the impairment of spatial learning and memory, reduce the level of apoptosis, and upregulate the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice; thus, appropriate interference of miR-142 may provide a potential therapeutic approach to rescue cognitive dysfunction in AD patients.

Collapse